|
1
|
Tissue Extract from Brittle Star Undergoing Arm Regeneration Promotes Wound Healing in Rat
Original Article
|
Marine Drugs
21(7):-
|
5.4
Q1
|
0.813
Q1
|
9.6
Q1
|
2023
|
1
|
|
2
|
Incorporation of curcumin into collagen-multiwalled carbon nanotubes nanocomposite scaffold: An in vitro and in vivo study
Original Article
|
Journal of Materials Research and Technology
21:4558-4576
|
6.4
Q1
|
1.05
Q1
|
8.5
Q1
|
2022
|
9
|
|
3
|
Efficacy and safety of topical brimonidine in dermatology: A review article
Review
|
Dermatologic Therapy
35(11):-
|
3.6
Q1
|
0.667
Q1
|
4.7
Q1
|
2022
|
0
|
|
4
|
Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris
Original Article
|
Dermatologic Therapy
35(10):-
|
3.6
Q1
|
0.667
Q1
|
4.7
Q1
|
2022
|
1
|
|
5
|
Comparison of the efficacy of intralesional 5-fluorouracil/lidocaine/epinephrine injection with cryotherapy to treat common and palmoplantar warts: A randomized, controlled trial
Original Article
|
Dermatologic Therapy
35(9):-
|
3.6
Q1
|
0.667
Q1
|
4.7
Q1
|
2022
|
3
|
|
6
|
Platelet-rich plasma and follicular transplantation versus follicular transplantation alone in the treatment of refractory vitiligo: A comparative pilot study
Research Letter
|
Dermatologic Therapy
35(8):-
|
3.6
Q1
|
0.667
Q1
|
4.7
Q1
|
2022
|
0
|
|
7
|
Immune Cell-Derived Extracellular Vesicles in the Face of Pathogenic Infections
Review
|
Frontiers in Immunology
13:-
|
7.3
Q1
|
2.022
Q1
|
9.4
Q1
|
2022
|
1
|
|
8
|
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis
Original Article
|
JAMA Dermatology
158(5):561-572
|
10.9
Q1
|
2.766
Q1
|
13.8
Q1
|
2022
|
11
|
|
9
|
Topical pentoxifylline can be an effective and safe adjunctive therapy to NBUVB therapy in treating vitiligo: A split-side clinical trial
Research Letter
|
Experimental Dermatology
31(2):255-256
|
3.6
Q1
|
0.934
Q1
|
7.2
Q1
|
2022
|
3
|
|
10
|
Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double-blind, split-site, randomized controlled trial
Original Article
|
Dermatologic Therapy
35(10):-
|
3.6
Q1
|
0.667
Q1
|
4.7
Q1
|
2022
|
1
|
